Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.

Also called NCT03699215

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 184 participants (planned count) (from the registry)
Sponsor
Hospital Universitario de Canarias (from the registry)
Registry
  • NCT NCT03699215
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03699215. Randomized; triple masking; primary purpose treatment. Start 2018-11-17 (actual); primary completion 2020-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan
Acronym
LEVOCEST
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Levosimendan
Intervention (Drug)
Placebos
Lead sponsor
Hospital Universitario de Canarias (class: other)

Record details

Record id
cardio:ct-nct03699215
Content hash
18ccf9c91b89cc9ec5512d1888327fe7ff948ff09f773c7df65d56f504c7a763